Skip to main content
. Author manuscript; available in PMC: 2010 Dec 13.
Published in final edited form as: Methods Enzymol. 2009;467:461–497. doi: 10.1016/S0076-6879(09)67018-X

Figure 7. Compartmental model of whole-body sVEGFR1 transport.

Figure 7

(A) sVEGFR1 has been postulated to have antagonistic effects on VEGF signaling complex formation (top row) through competitive binding of VEGF ligands (middle row) and dominant-negative heterodimerization with endothelial cell-surface VEGF receptors (bottom row). (B) Sample simulations of the ligand-trapping effects of intravascularly administered exogenous sVEGFR1 based on results previously published in (Wu et al., 2009a).